Authors |
Costacou T, Levy AP, Miller RG, Snell-Bergeon J, Asleh R, Farbstein D, Fickley CE, Pambianco G, de la Vega R, Evans RW, Orchard TJ
|
Submitted By |
Tina Costacou on 10/28/2016 |
Status |
Published |
Journal |
Acta diabetologica |
Year |
2016 |
Date Published |
4/1/2016 |
Volume : Pages |
53 : 243 - 50 |
PubMed Reference |
|
Abstract |
Haptoglobin (Hp) genotype 2-2 increases cardiovascular diabetes complications. In type 2 diabetes, a-tocopherol was shown to lower cardiovascular risk in Hp 2-2, potentially through HDL function improvements. Similar type 1 diabetes data are lacking. We conducted a randomized crossover pilot of a-tocopherol supplementation on HDL function [i.e., cholesterol efflux (CE) and HDL-associated lipid peroxides (LP)] and lipoprotein subfractions in type 1 diabetes., Hp genotype was assessed in members of two Allegheny County, PA, type 1 diabetes registries and the CACTI cohort; 30 were randomly selected within Hp genotype, and 28 Hp 1-1, 31 Hp 2-1 and 30 Hp 2-2 were allocated to daily a-tocopherol or placebo for 8聽weeks with a 4-week washout., Baseline CE decreased with the number of Hp 2 alleles (p-trend聽=聽0.003). There were no differences in LP or lipoprotein subfractions. In intention-to-treat analysis stratified by Hp, a-tocopherol increased CE in Hp 2-2 (脽聽=聽0.79, p聽=聽0.03) and LP in Hp 1 allele carriers (脽 Hp 1-1聽=聽0.18, p聽=聽0.05; 脽 Hp 2-1聽=聽0.21, p聽=聽0.07); reduced HDL particle size (脽聽=聽-0.07, p聽=聽0.03) in Hp 1-1 carriers; increased LDL particle concentration in Hp 1-1; and decreased it in Hp 2-2 carriers. However, no significant interactions were observed by Hp., In this type 1 diabetes study, HDL function worsened with the number of Hp 2 alleles. a-Tocopherol improved HDL function in Hp 2-2 carriers and appeared to adversely affect lipid peroxides and lipoprotein subfractions among Hp 1 allele carriers. As no significant interactions were observed, findings require replication in larger studies.
|
|
|